טנובמד אינובמד ישראל - עברית - Ministry of Health

טנובמד אינובמד

inovamed ltd - emtricitabine; tenofovir disoproxil as fumarate - טבליות מצופות פילם - tenofovir disoproxil as fumarate 245 mg; emtricitabine 200 mg - tenofovir disoproxil and emtricitabine

דולוטרמד אינובמד 50 מג ישראל - עברית - Ministry of Health

דולוטרמד אינובמד 50 מג

inovamed pharma ltd, israel - dolutegravir as sodium - טבליות מצופות פילם - dolutegravir as sodium 50 mg - dolutegravir

פירפנידון אינובמד 267 מג   ישראל - עברית - Ministry of Health

פירפנידון אינובמד 267 מג

inovamed pharma ltd, israel - pirfenidone - טבליות מצופות פילם - pirfenidone 267 mg - pirfenidone

פירפנידון אינובמד 801 מג   ישראל - עברית - Ministry of Health

פירפנידון אינובמד 801 מג

inovamed pharma ltd, israel - pirfenidone - טבליות מצופות פילם - pirfenidone 801 mg - pirfenidone

מיקרולט ישראל - עברית - Ministry of Health

מיקרולט

dexcel ltd, israel - glycerol; laurylsulphoacetate sodium; sodium citrate - חוקן - glycerol 12.5 %w/v; sodium citrate 9 %w/v; laurylsulphoacetate sodium 0.9 %w/v - combinations

צפזולין סנדוז 0.5 גרם ישראל - עברית - Ministry of Health

צפזולין סנדוז 0.5 גרם

masrouji company ltd - cefazolin as sodium 500 mg/vial - powder for solution for injection - cefazolin - treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis. treatment respiratory tract: respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae) klebsiella species haemophilus influenzae staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a b - hemolytic streptococci. cefazolin is effective in the eradication of streptococci from the nasopharynx. however data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. urinary tract: infections due to escherichia coli klebsiella species proteus mirabilis and some strains of enterobacter and enterococci. skin and skin structure: -hemolytic beta infections due to staphylococcus aureus (penicillin-sensitive and penicillin-resistant) group a streptococci and other strains of streptococci. biliary tract: infections due to escherichia coli various strains of streptococci proteus mirabilis klebsiella

צפאזול 1 גרם ישראל - עברית - Ministry of Health

צפאזול 1 גרם

novartis israel ltd - cefazolin as sodium - אבקה להכנת תמיסה לזריקה - cefazolin as sodium 1 g/vial - cefazolin - cefazolin - treatment of serious infections caused by susceptible organisms and also perioperatively for prophylaxis. treatment respiratory tract: respiratory tract infections due to streptococcus pneumoniae (formerly diplococcus pneumoniae) klebsiella species haemophilus influenzae staphylococcus aureus (penicillin-sensitive and penicillin-resistant) and group a b - hemolytic streptococci. cefazolin is effective in the eradication of streptococci from the nasopharynx. however data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. urinary tract: infections due to escherichia coli klebsiella species proteus mirabilis and some strains of enterobacter and enterococci. skin and skin structure: -hemolytic beta infections due to staphylococcus aureus (penicillin-sensitive and penicillin-resistant) group a streptococci and other strains of streptococci. biliary tract: infections due to escherichia coli various strains of streptococci proteus mirabilis klebsiella

קובקטן LC וטרינרי ישראל - עברית - Ministry of Health

קובקטן lc וטרינרי

intervet ( israel) ltd - cefquinome as sulfate - משחה - cefquinome as sulfate 75 mg/vial

אזיתרומיצין אינובמד 250 מג ישראל - עברית - Ministry of Health

אזיתרומיצין אינובמד 250 מג

inovamed ltd - azithromycin as dihydrate - קפסולות - azithromycin as dihydrate 250 mg - azithromycin

נאורונטין 300 מג ישראל - עברית - Ministry of Health

נאורונטין 300 מג

pfizer pfe pharmaceuticals israel ltd - gabapentin - קפסולות - gabapentin 300 mg - gabapentin - gabapentin - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy.